{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:40:37Z","timestamp":1793371237919,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81530012"],"award-info":[{"award-number":["81530012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>High-mobility group AT-hook1 (HMGA1, formerly HMG-I\/Y), an architectural transcription factor, participates in a number of biological processes. However, its effect on cardiac remodeling (refer to cardiac inflammation, apoptosis and dysfunction) in diabetic cardiomyopathy remains largely indistinct. In this study, we found that HMGA1 was upregulated in diabetic mouse hearts and high-glucose-stimulated cardiomyocytes. Overexpression of HMGA1 accelerated high-glucose-induced cardiomyocyte inflammation and apoptosis, while HMGA1 knockdown relieved inflammation and apoptosis in cardiomyocytes in response to high glucose. Overexpression of HMGA1 in mice heart by adeno-associated virus 9 (AAV9) delivery system deteriorated the inflammatory response, increased apoptosis and accelerated cardiac dysfunction in streptozotocin-induced diabetic mouse model. Knockdown of HMGA1 by AAV9-shHMGA1 in vivo ameliorated cardiac remodeling in diabetic mice. Mechanistically, we found that HMGA1 inhibited the formation rather than the degradation of autophagy by regulating P27\/CDK2\/mTOR signaling. CDK2 knockdown or P27 overexpression blurred HMGA1 overexpression-induced deteriorating effects in vitro. P27 overexpression in mice heart counteracted HMGA1 overexpression-induced increased cardiac remodeling in diabetic mice. The luciferase reporter experiment confirmed that the regulatory effect of HMGA1 on P27 was mediated by miR-222. In addition, a miR-222 antagomir counteracted HMGA1 overexpression-induced deteriorating effects in vitro. Taken together, our data indicate that HMGA1 aggravates diabetic cardiomyopathy by directly regulating miR-222 promoter activity, which inhibits P27\/mTOR-induced autophagy.<\/jats:p>","DOI":"10.1038\/s41419-020-2316-4","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T15:03:24Z","timestamp":1583161404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7475-5014","authenticated-orcid":false,"given":"Qing-Qing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhulan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"2316_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","volume":"34","author":"WB Kannel","year":"1974","unstructured":"Kannel, W. B., Hjortland, M. & Castelli, W. P. Role of diabetes in congestive heart failure: the Framingham study. Am. J. Cardiol. 34, 29\u201334 (1974).","journal-title":"Am. J. Cardiol."},{"key":"2316_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","volume":"3","author":"AD Shah","year":"2015","unstructured":"Shah, A. D. et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 3, 105\u2013113 (2015).","journal-title":"ancet Diabetes Endocrinol."},{"key":"2316_CR3","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1161\/01.CIR.0000143376.64970.4A","volume":"110","author":"N Carrabba","year":"2004","unstructured":"Carrabba, N. et al. Left ventricular remodeling and heart failure in diabetic patients treated with primary angioplasty for acute myocardial infarction. Circulation 110, 1974\u20131979 (2004).","journal-title":"Circulation"},{"key":"2316_CR4","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/HJH.0b013e3282fe1d3d","volume":"26","author":"G Tocci","year":"2008","unstructured":"Tocci, G., Sciarretta, S. & Volpe, M. Development of heart failure in recent hypertension trials. J. Hypertension 26, 1477\u20131486 (2008).","journal-title":"J. Hypertension"},{"key":"2316_CR5","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/eurheartj\/ehp055","volume":"30","author":"X Du","year":"2009","unstructured":"Du, X. et al. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur. Heart J. 30, 1128\u20131135 (2009).","journal-title":"Eur. Heart J."},{"key":"2316_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"G Jia","year":"2018","unstructured":"Jia, G., Whaley-Connell, A. & Sowers, J. R. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia 61, 21\u201328 (2018).","journal-title":"Diabetologia"},{"key":"2316_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-018-0684-1","volume":"17","author":"N Ghosh","year":"2018","unstructured":"Ghosh, N. & Katare, R. Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides. Cardiovascular Diabetol. 17, 43 (2018).","journal-title":"Cardiovascular Diabetol."},{"key":"2316_CR8","doi-asserted-by":"publisher","first-page":"8602041","DOI":"10.1155\/2018\/8602041","volume":"2018","author":"R Ghosh","year":"2018","unstructured":"Ghosh, R. & Pattison, J. S. Macroautophagy and chaperone-mediated autophagy in heart failure: the known and the unknown. Oxid. Med. Cell. Longev. 2018, 8602041 (2018).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"2316_CR9","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.2337\/db10-0351","volume":"60","author":"Z Xie","year":"2011","unstructured":"Xie, Z. et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes 60, 1770\u20131778 (2011).","journal-title":"Diabetes"},{"key":"2316_CR10","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.bbadis.2018.02.012","volume":"1864","author":"Y Xiao","year":"2018","unstructured":"Xiao, Y. et al. TAX1BP1 overexpression attenuates cardiac dysfunction and remodeling in STZ-induced diabetic cardiomyopathy in mice by regulating autophagy. Biochim. Biophys. Acta 1864, 1728\u20131743 (2018).","journal-title":"Biochim. Biophys. Acta"},{"key":"2316_CR11","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2337\/db12-0533","volume":"62","author":"C He","year":"2013","unstructured":"He, C. et al. Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes 62, 1270\u20131281 (2013).","journal-title":"Diabetes"},{"key":"2316_CR12","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/CIRCULATIONAHA.111.078212","volume":"125","author":"S Sciarretta","year":"2012","unstructured":"Sciarretta, S. et al. Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation 125, 1134\u20131146 (2012).","journal-title":"Circulation"},{"key":"2316_CR13","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nrc2271","volume":"7","author":"A Fusco","year":"2007","unstructured":"Fusco, A. & Fedele, M. Roles of HMGA proteins in cancer. Nat. Rev. Cancer 7, 899\u2013910 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"2316_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-1-4615-1809-9_28","volume":"1","author":"R Reeves","year":"1995","unstructured":"Reeves, R. & Nissen, M. S. Cell cycle regulation and functions of HMG-I(Y). Prog. Cell Cycle Res. 1, 339\u2013349 (1995).","journal-title":"Prog. Cell Cycle Res."},{"key":"2316_CR15","first-page":"2276","volume":"57","author":"A Tkachenko","year":"1997","unstructured":"Tkachenko, A. et al. Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis. Cancer Res. 57, 2276\u20132280 (1997).","journal-title":"Cancer Res."},{"key":"2316_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030034","volume":"7","author":"A Belton","year":"2012","unstructured":"Belton, A. et al. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells. PLoS ONE 7, e30034 (2012).","journal-title":"PLoS ONE"},{"key":"2316_CR17","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1054\/bjoc.2000.1494","volume":"83","author":"G Giannini","year":"2000","unstructured":"Giannini, G. et al. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status. Br. J. Cancer 83, 1503\u20131509 (2000).","journal-title":"Br. J. Cancer"},{"key":"2316_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0683-x","volume":"9","author":"F Fu","year":"2018","unstructured":"Fu, F. et al. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration\/invasion via targeting miR-221\/222 in cervical cancer. Cell Death Dis. 9, 594 (2018).","journal-title":"Cell Death Dis."},{"key":"2316_CR19","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1158\/0008-5472.CAN-05-1889","volume":"66","author":"M Fedele","year":"2006","unstructured":"Fedele, M. et al. Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res. 66, 2536\u20132543 (2006).","journal-title":"Cancer Res."},{"key":"2316_CR20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1134\/S0006297914060078","volume":"79","author":"XY You","year":"2014","unstructured":"You, X. Y. et al. HMGA1 is a new target of miR-195 involving isoprenaline-induced cardiomyocyte hypertrophy. Biochemistry (Moscow) 79, 538\u2013544 (2014).","journal-title":"Biochemistry (Moscow)"},{"key":"2316_CR21","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.115.020617","volume":"133","author":"RK Hopper","year":"2016","unstructured":"Hopper, R. K. et al. In pulmonary arterial hypertension, reduced BMPR2 promotes endothelial-to-mesenchymal transition via HMGA1 and its target slug. Circulation 133, 1783\u20131794 (2016).","journal-title":"Circulation"},{"key":"2316_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jacbts.2016.08.008","volume":"1","author":"T Knezevic","year":"2016","unstructured":"Knezevic, T. et al. Adeno-associated virus serotype 9\u2014driven expression of BAG3 improves left ventricular function in murine hearts with left ventricular dysfunction secondary to a myocardial infarction. JACC Basic Transl. Sci. 1, 647\u2013656 (2016).","journal-title":"JACC Basic Transl. Sci."},{"key":"2316_CR23","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1042\/CS20160074","volume":"130","author":"QQ Wu","year":"2016","unstructured":"Wu, Q. Q. et al. OX40 regulates pressure overload-induced cardiac hypertrophy and remodelling via CD4+ T-cells. Clin. Sci. 130, 2061\u20132071 (2016).","journal-title":"Clin. Sci."},{"key":"2316_CR24","doi-asserted-by":"publisher","first-page":"H1143","DOI":"10.1152\/ajpheart.00601.2014","volume":"308","author":"QQ Wu","year":"2015","unstructured":"Wu, Q. Q. et al. Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-alpha\/ASK1\/JNK pathway. Am. J. Physiol. Heart Circulatory Physiol. 308, H1143\u2013H1154 (2015).","journal-title":"Am. J. Physiol. Heart Circulatory Physiol."},{"key":"2316_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-1-4939-2537-7_8","volume":"1294","author":"O Lomas","year":"2015","unstructured":"Lomas, O. et al. Adenoviral transduction of FRET-based biosensors for cAMP in primary adult mouse cardiomyocytes. Methods Mol. Biol. 1294, 103\u2013115 (2015).","journal-title":"Methods Mol. Biol."},{"key":"2316_CR26","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1111\/bph.13449","volume":"173","author":"ZG Ma","year":"2016","unstructured":"Ma, Z. G. et al. Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor\/AMPKalpha signalling pathway. Br. J. Pharmacol. 173, 1502\u20131516 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"2316_CR27","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.1055\/s-0043-122577","volume":"84","author":"Y Xiao","year":"2018","unstructured":"Xiao, Y. et al. Aucubin protects against TGF\u03b21-induced cardiac fibroblasts activation by mediating the AMPK\u03b1\/mTOR signaling pathway. Planta Med. 84, E2 (2018).","journal-title":"Planta Med."},{"key":"2316_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbadis.2014.05.020","volume":"1852","author":"S Kobayashi","year":"2015","unstructured":"Kobayashi, S. & Liang, Q. Autophagy and mitophagy in diabetic cardiomyopathy. Biochim. Biophys. Acta 1852, 252\u2013261 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"2316_CR29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11010-011-0907-1","volume":"357","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells. Mol. Cell. Biochem. 357, 363\u2013371 (2011).","journal-title":"Mol. Cell. Biochem."},{"key":"2316_CR30","doi-asserted-by":"publisher","first-page":"45462","DOI":"10.18632\/oncotarget.9990","volume":"7","author":"KA Lloyd","year":"2016","unstructured":"Lloyd, K. A. et al. Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1. Oncotarget 7, 45462\u201345478 (2016).","journal-title":"Oncotarget"},{"key":"2316_CR31","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/cdd.2017.117","volume":"24","author":"A Conte","year":"2017","unstructured":"Conte, A. et al. High mobility group A1 protein modulates autophagy in cancer cells. Cell Death Differ. 24, 1948\u20131962 (2017).","journal-title":"Cell Death Differ."},{"key":"2316_CR32","first-page":"709","volume":"17","author":"D Bhattacharya","year":"2018","unstructured":"Bhattacharya, D., Mukhopadhyay, M., Bhattacharyya, M. & Karmakar, P. Is autophagy associated with diabetes mellitus and its complications? A review. EXCLI J. 17, 709\u2013720 (2018).","journal-title":"EXCLI J."},{"key":"2316_CR33","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4161\/auto.6.5.11947","volume":"6","author":"M Taneike","year":"2010","unstructured":"Taneike, M. et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 6, 600\u2013606 (2010).","journal-title":"Autophagy"},{"key":"2316_CR34","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm1574","volume":"13","author":"A Nakai","year":"2007","unstructured":"Nakai, A. et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 13, 619\u2013624 (2007).","journal-title":"Nat. Med."},{"key":"2316_CR35","doi-asserted-by":"publisher","first-page":"41095","DOI":"10.1074\/jbc.M313084200","volume":"279","author":"H Akazawa","year":"2004","unstructured":"Akazawa, H. et al. Diphtheria toxin-induced autophagic cardiomyocyte death plays a pathogenic role in mouse model of heart failure. J. Biol. Chem. 279, 41095\u201341103 (2004).","journal-title":"J. Biol. Chem."},{"key":"2316_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijcard.2008.01.043","volume":"134","author":"L Lu","year":"2009","unstructured":"Lu, L. et al. Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure. Int. J. Cardiol. 134, 82\u201390 (2009).","journal-title":"Int. J. Cardiol."},{"key":"2316_CR37","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.yjmcc.2011.03.002","volume":"50","author":"KM Mellor","year":"2011","unstructured":"Mellor, K. M. et al. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J. Mol. Cell. Cardiol. 50, 1035\u20131043 (2011).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2316_CR38","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1002\/jcb.26041","volume":"118","author":"Y Xiao","year":"2017","unstructured":"Xiao, Y. et al. Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy. J. Cell. Biochem. 118, 3899\u20133910 (2017).","journal-title":"J. Cell. Biochem."},{"key":"2316_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","volume":"121","author":"L Ma","year":"2005","unstructured":"Ma, L. et al. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179\u2013193 (2005).","journal-title":"Cell"},{"key":"2316_CR40","doi-asserted-by":"publisher","first-page":"7882","DOI":"10.1158\/0008-5472.CAN-10-1604","volume":"70","author":"H Jiang","year":"2010","unstructured":"Jiang, H. et al. The RB-E2F1 pathway regulates autophagy. Cancer Res. 70, 7882\u20137893 (2010).","journal-title":"Cancer Res."},{"key":"2316_CR41","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/cdd.2014.187","volume":"22","author":"M Su","year":"2015","unstructured":"Su, M. et al. MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27\/CDK2\/mTOR axis. Cell Death Differ. 22, 986\u2013999 (2015).","journal-title":"Cell Death Differ."},{"key":"2316_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0092-8674(94)90573-8","volume":"78","author":"H Toyoshima","year":"1994","unstructured":"Toyoshima, H. & Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67\u201374 (1994).","journal-title":"Cell"},{"issue":"12","key":"2316_CR43","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1111\/jcmm.13866","volume":"22","author":"Ying Huang","year":"2018","unstructured":"Huang, Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J. Cell. Mol. Med. 22, 5768\u20135775 (2018).","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"2316_CR44","doi-asserted-by":"publisher","first-page":"E918","DOI":"10.21037\/jtd.2016.08.93","volume":"8","author":"K Zhu","year":"2016","unstructured":"Zhu, K. et al. Developing miRNA therapeutics for cardiac repair in ischemic heart disease. J. Thorac. Dis. 8, E918\u2013E927 (2016).","journal-title":"J. Thorac. Dis."},{"key":"2316_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.carpath.2012.07.004","volume":"22","author":"M Asrih","year":"2013","unstructured":"Asrih, M. & Steffens, S. Emerging role of epigenetics and miRNA in diabetic cardiomyopathy. Cardiovasc. Pathol. 22, 117\u2013125 (2013).","journal-title":"Cardiovasc. Pathol."},{"key":"2316_CR46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000480371","volume":"43","author":"Y Xu","year":"2017","unstructured":"Xu, Y. et al. MicroRNA-222 promotes the proliferation of pulmonary arterial smooth muscle cells by targeting P27 and TIMP3. Cell. Physiol. Biochem. 43, 282\u2013292 (2017).","journal-title":"Cell. Physiol. Biochem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2316-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2316-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2316-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:48:23Z","timestamp":1670251703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2316-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["2316"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2316-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"13 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"160"}}